Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Mutation Analysis of Exons 10 and 17a of CFTR Gene in Patients with Cystic Fibrosis in Kermanshah Province, Western Iran

Authors
1 Department of Biology, Faculty of Islamic Azad University, Jahrom Branch, Jahrom, Iran
2 Nano Drug Delivery Research Centre, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Nosocomial Infectious Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract
Background: Cystic fibrosis (CF) is the most common genetic disorder with autosomal recessive inheritance among Caucasian populations. So far, more than 1950 different mutations were identified in cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR gene has 27 exons. The type and distribution of mutations vary widely among different countries and/or ethnic groups. Therefore, a comprehensive analysis was performed on exon10 and exon17a of CFTR gene in CF patients in the Kermanshah province, western Iran. Methods: We tested 27 patients admitted to the medical genetics laboratory of Kermanshah University of Medical Sciences. The patients were from different cities of Kermanshah province. All the patients had the clinical signals and two positive sweat tests. After filling agreement forms and questionnaire, the peripheral blood sampling and DNA extraction were done. DNA samples were extracted. PCR and sequencing special PCR were done. Finally analysis of the results with DNA sequencing analysis version 5.2 software was performed. Results: CFTR mutations analysis identified 4 different mutations in our CF patients. The disease-causing mutations were p.F508del (∆F508) (14.81%), p.S466X (1.85%), and p.T1036I (1.85%). M470V polymorphism with frequency of 74.1% was found in 23 patients (17 homozygous and 6 heterozygous). Conclusion: Three disease-causing mutations in CF patients in the present study account for approximately 18.51% of mutations. The frequency of p.F508del, the most common mutation was 1618.1% in Iranian population. The results of the present study can be applied for genetic counseling, population screening and prenatal diagnosis.
Keywords

  1. Allen J, Panitch H, Rubenstein R, editors. Cystic fibrosis. New York: Informa Healthcare USA; c2010. 1-3 p. (Kreindler JL, Foskett JK, editors. Lung biology in health and disease series; vol. 242).
  2. Geborek A, Hjelte L. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations. J Cyst Fibros. 2011;10(3): 187-92.
  3. Dorwart M, Thibodeau P, Thomas P. Cystic fibrosis: recent structural insights. J Cyst Fibros. 2004;3 Suppl 2:91-4.
  4. Rommens JM. Cystic Fibrosis Mutation Database [Internet]. Toronto (CA): The Hospital for Sick Children; 1989 [updated 2011 Apr 25; cited 2013 Dec 20). Available from: http://www.genet.sickkids. on.ca/Home.html.
  5. Estivill X, Bancells C, Ramos C. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat. 1997;10 (2):135-54.
  6. Dawson KP, Frossard PM. The geographic distribution of cystic fibrosis mutations gives clues about population origins. Eur J Pediatr. 2000;159(7):496-9.
  7. Shah U, Frossard P, Moatter T. Cystic fibrosis: defining a disease under-diagnosed in Pakistan. Trop Med Int Health. 2009;14(5):542-5.
  8. Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J Cyst Fibros. 2008;7(2):102-9.
  9. Elahi E, Khodadad A, Kupershmidt I, Ghasemi F, Alinasab B, Naghizadeh R, et al. A haplotype framework for cystic fibrosis mutations in Iran. J Mol Diagn. 2006;8(1):119-27.
  10. Alibakhshi R, Zamani M. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients. Iran J Allergy Asthma Immunol. 2006;5(1):3-8.
  11. Wikipedia, the free encyclopedia. Kurdish people [Internet]. Wikimedia Foundation, Inc; 2001 Jan 10 [updated 2013 Aug 14; cited 2013 Aug 20]. Available from: http://en.wikipedia.org/wiki/Kurdish_people.
  12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
  13. Mateu E, Calafell F, Ramos MD, Casals T, Bertranpetit J. Can a place of origin of the main cystic fibrosis mutations be identified?. Am J Hum Genet. 2002;70(1):257-64.
  14. Loumi O, Ferec C, Mercier B, Creff J, Fercot B, Denine R, et al. CFTR mutations in the Algerian population. J Cyst Fibros. 2008;7(1):54-9.
  15. Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Hum Mutat. 2002;19(6):575-606.
  16. Sharma N, Singh M, Kaur G, Thapa BR, Prasad R. Identification and characterization of CFTR gene mutations in Indian CF patients. Ann Hum Genet. 2009;73(1):26-33.
  17. Shastri SS, Kabra M, Kabra SK, Pandey RM, Menon PS. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India. J Cyst Fibros. 2008;7(2):110-5.
  18. Kilinc MO, Ninis VN, Dagli E, Demirkol M, Ozkinay F, Arikan Z, et al. Highest heterogeneity for cystic fibrosis: 36 mutations account for 75% of all CF chromosomes in Turkish patients. Am J Med Genet. 2002;113(3):250-7.
  19. Rawashdeh M, Manal H. Cystic fibrosis in Arabs: a prototype from Jordan. Ann Trop Paediatr. 2000;20(4):283-6.
  20. Wahab AA, Janahi IA, Hebi S, al-Hamed M, Kambouris M. Cystic fibrosis in a child from Syria. Ann Trop Paediatr. 2002;22(1):53-5.
  21. Kambouris M, Banjar H, Moggari I, Nazer H, Al-Hamed M, Meyer BF. Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations. Eur J Pediatr. 2000;159(5):303-9.
  22. el-Harith EA, Dork T, Stuhrmann M, Abu-Srair H, al-Shahri A, Keller KM, et al. Novel and characteristic CFTR mutations in Saudi Arab children with severe cystic fibrosis. 1997;34(12):996-9.
  23. Banjar H. Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia. East Mediterr Health J. 1999;5(6):1230-5.
  24. Eskandarani HA. Cystic fibrosis transmembrane regulator gene mutations in Bahrain. J Trop Pediatr. 2002;48(6):348-50.
  25. Lucotte G, Barre E, Berriche S. Frequency of the cystic fibrosis mutation delta F508 in Algeria. Hum Genet. 1991;87(6):759.
  26. Messaoud T, Verlingue C, Denamur E, Pascaud O, Quere I, Fattoum S, et al. Distribution of CFTR mutations in cystic fibrosis patients of Tunisian origin: identification of two novel mutations. Eur J Hum Genet. 1996;4(1):20-4.
  27. Saleheen D, Frossard PM. The cradle of the deltaF508 mutation. J Ayub Med Coll Abbottabad. 2008;20(4):157-60.
  28. Schwartz M, Johansen HK, Koch C, Brandt NJ. Frequency of the delta F508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet. 1990;85(4):427-8.
  29. McIntosh I, Lorenzo ML, Brock DJ. Frequency of delta F508 mutation on cystic fibrosis chromosomes in UK. Lancet. 1989;2(8676):1404-5.
  30. Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG). Hum Genet. 1990;85 (4):436-45.
  31. Casals T, Ramos MD, Gimenez J, Larriba S, Nunes V, Estivill X. High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes. Hum Genet. 1997;101(3):365-70.
  32. Tzetis M, Kanavakis E, Antoniadi T, Doudounakis S, Adam G, Kattamis C. Characterization of more than 85% of cystic fibrosis alleles in the Greek population, including five novelmutations. Hum Genet. 1997;99(1):121-5.
  33. Onay T, Zielenski J, Topaloglu O, Gokgoz N, Kayserili H, Apak MY, et al. Cystic fibrosis mutations and associated haplotypes in Turkish cystic fibrosis patients. Hum Biol. 2001;73(2):191-203.
  34. Castellani C, Cuppens H, Macek M Jr, Cassiman JJ, Kerem E, Durie P, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008;7(3):179-96.
  35. Ciminelli BM, Bonizzato A, Bombieri C, Pompei F, Gabaldo M, Ciccacci C, et al. Highly preferential association of Non F508del CF mutations with the M470 allele. J Cyst Fibros. 2007;6(1):15-22.
  36. Cuppens H, Cassiman JJ. CFTR mutations and polymorphisms in male infertility. Int J Androl. 2004;27(5):251-6.
  37. Qiao D, Yi L, Hua L, Xu Z, Ding Y, Shi D, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: a case-control study in Chinese Han population. J Cyst Fibros. 2008;7(3):210-4.
  38. O'Donnell DH, Ryan R, Hayes B, Fennelly D, Gibney RG. Hepatocellular carcinoma complicating cystic fibrosis related liver disease. J Cyst Fibros. 2009;8(4):288-90.